Comprehensive Evaluation of Deubiquitinating Enzymes in Colorectal Cancer: Mechanistic Insights and Potential Therapeutic Approaches - Top-Institutions - MDSpire

Comprehensive Evaluation of Deubiquitinating Enzymes in Colorectal Cancer: Mechanistic Insights and Potential Therapeutic Approaches

  • By

  • Ting Wang

  • Pingying Li

  • Shuo Xu

  • Guocai Xu

  • April 23, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Molecular Cancer Biology
    • Translational Research

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Cancer Biology
    • Experimental Therapeutics
    • Gastrointestinal Oncology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Molecular Therapeutics
    • Cancer Genomics

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Cancer Biology
    • Molecular Oncology
    • Gastrointestinal Cancers

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Cancer Research
    • Molecular Therapeutics
    • Immuno-oncology

Original Source(s)

Comprehensive Evaluation of Deubiquitinating Enzymes in Colorectal Cancer: Mechanistic Insights and Potential Therapeutic Approaches

  • by Ting Wang, Pingying Li, Shuo Xu, Guocai Xu

  • April 23, 2026

Related Content

Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors

Reply to: Clarifying multimodal inputs and attribution in colorectal cancer survival prediction